Author
1. Iyengar Arpana
2. Jha Vivekanand
3. Modi Gopesh K
ISBN
9789352705115
DOI
10.5005/jp/books/18440_138
Edition
1/e
Publishing Year
2018
Pages
1
Author Affiliations
1.
St. John’s Medical College and Hospital, Bengaluru, Karnataka, India,
St John’s Medical College Hospital, Bengaluru, Karnataka, India,
St John’s Medical College, Bengaluru, Karnataka, India,
Children’s Kidney Care Centre, St John’s National Academy of Health Sciences, Bengaluru, Karnataka, India,
St. John's National Academy of Health Sciences, Bangalore, Karnataka, India
2.
Postgraduate Institute of Medical, Education and Research, Chandigarh,
Coordinator of Stem Cell Research Facility, P.G.I.M.E.R., Chandigarh, India,
Postgraduate Institute of Medical Education and Research, Chandigarh, India,
The George Institute for Global Health, India; James Martin Fellow, University of Oxford; University of New South Wales, Sydney, Australia; International Society of Nephrology,
George Institute for Global Health, India, New Delhi, India; Global Kidney Health Imperial College, London, United Kingdom,
The George Institute for Global Health; Fortis Escorts Hospital, New Delhi, India,
The George Institute for Global Health, Fortis Escorts Hospital, New Delhi, India,
George Institute for Global Health, New Delhi, India; Global Kidney Health, Imperial College, London, UK; Aykai Hospital, Ludhiana, Punjab, India,
George Institute for Global Health, New Delhi, India; Chair of Global Kidney Health, Imperial College, London, UK; Aykai Hospital, Ludhiana, Punjab, India
3.
Noble Samarpan Kidney Centre, Bhopal, Madhya Pradesh, India,
Noble-Samarpan Kidney Centre, Bhopal, Madhya Pradesh, India
Chapter keywords
Oral methylprednisolone,
clinical outcome,
IgA nephropathy,
randomized clinical trial,
therapeutic evaluation,
steroid,
renin–angiotensin–aldosterone system,
RAAS,
end stage renal disease
